Planta Med 2006; 72(8): 761-763
DOI: 10.1055/s-2006-931600
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Evaluation of the Anti-Trypanosomal Activity of Tyropeptin A

Dietmar Steverding1 , 2 , Alexander J. Pemberton3 , Howard Royle2 , Robert W. Spackman2 , A. Jennifer Rivett3
  • 1Biomedical Research Centre, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
  • 2School of Biological Sciences, University of Bristol, Bristol, UK
  • 3Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, UK
Weitere Informationen

Publikationsverlauf

Received: December 1, 2005

Accepted: March 5, 2006

Publikationsdatum:
29. Mai 2006 (online)

Preview

Abstract

The natural compound tyropeptin A, a new peptidyl aldehyde proteasome inhibitor, was tested for its trypanocidal activity in vitro using culture-adapted bloodstream forms of Trypanosoma brucei. The concentrations of tyropeptin A required to reduce the growth rate by 50 % and to kill all cells were 10 and 100 times lower for bloodstream-form trypanosomes than for human leukaemia HL-60 cells, respectively. Enzymatic analysis showed that the trypsin-like activity of the trypanosome proteasome and the chymotrypsin-like activity of the mammalian proteasome are particularly sensitive to inhibition by tyropeptin A. The results suggest that natural compounds targeting the trypsin-like activity of the proteasome may serve as leads for rational drug development of novel anti-trypanosomal agents.

References

Priv.-Doz. Dr. Dietmar Steverding

School of Medicine, Health Policy and Practice

University of East Anglia

Norwich NR4 7TJ

United Kingdom

Fax: +44-1603-59-3752

eMail: dsteverding@hotmail.com